EU Safety Signal Detection Pilot Extended Again
Few Signals And A Lot Of Work
Executive Summary
The pilot phase of a European project on new safety signal notification requirements has been extended for a second time following inconclusive results.
You may also be interested in...
Pharma Disappointed By New Extension Of EU Signal Detection Pilot
A further extension of the EU signal detection pilot means that certain drug sponsors must keep monitoring the EudraVigilance database on a continuous basis. Industry argues there is enough evidence that this activity brings no additional value, and that current requirements should be replaced with a more proportionate approach.
Wait For Benefits Of EudraVigilance Pilot Before Expanding To More EU Products, Says Pharma
Drug companies say that any decision on taking the EudraVigilance monitoring requirements into the next phase should only be made when there is clear evidence that it has improved patient safety.
EU Extends Pilot Of New Drug Safety Reporting System
Testing of the enhanced EU drug safety reporting system, EudraVigilance, is to be extended beyond February in an effort to gain more information on how stakeholders are finding the new requirements.